Alexandre Bleibtreu

2.2k total citations
61 papers, 949 citations indexed

About

Alexandre Bleibtreu is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Alexandre Bleibtreu has authored 61 papers receiving a total of 949 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 19 papers in Epidemiology and 15 papers in Pharmacology. Recurrent topics in Alexandre Bleibtreu's work include Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and COVID-19 Clinical Research Studies (10 papers). Alexandre Bleibtreu is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and COVID-19 Clinical Research Studies (10 papers). Alexandre Bleibtreu collaborates with scholars based in France, United Kingdom and Netherlands. Alexandre Bleibtreu's co-authors include Xavier Monnet, Jean–Louis Teboul, Christian Richard, Alexis Ferré, Martin Dres, Érick Denamur, Olivier Clermont, R. Gharbi, Nadhira Houhou‐Fidouh and C. Bertin and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Bacteriology.

In The Last Decade

Alexandre Bleibtreu

55 papers receiving 926 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandre Bleibtreu France 17 282 235 224 196 163 61 949
Sami Hraiech France 28 249 0.9× 257 1.1× 463 2.1× 145 0.7× 68 0.4× 91 2.0k
Anne Marie G. A. de Smet Netherlands 20 144 0.5× 196 0.8× 492 2.2× 464 2.4× 93 0.6× 42 1.5k
Peter W. Schreiber Switzerland 17 109 0.4× 318 1.4× 421 1.9× 114 0.6× 28 0.2× 57 1.1k
Matthaios Papadimitriou‐Olivgeris Switzerland 19 94 0.3× 552 2.3× 490 2.2× 530 2.7× 150 0.9× 98 1.3k
Kerrie Watson Australia 16 135 0.5× 340 1.4× 287 1.3× 173 0.9× 57 0.3× 23 900
Dimitra Dimopoulou Greece 17 99 0.4× 233 1.0× 351 1.6× 276 1.4× 142 0.9× 63 898
Luis Felipe Reyes Colombia 26 135 0.5× 831 3.5× 849 3.8× 203 1.0× 46 0.3× 107 2.0k
Vincenzo Russotto Italy 17 74 0.3× 222 0.9× 132 0.6× 113 0.6× 43 0.3× 35 872
Naomi Runnegar Australia 14 110 0.4× 144 0.6× 156 0.7× 220 1.1× 149 0.9× 35 928
Guy W. Soo Hoo United States 23 92 0.3× 189 0.8× 469 2.1× 88 0.4× 36 0.2× 52 1.7k

Countries citing papers authored by Alexandre Bleibtreu

Since Specialization
Citations

This map shows the geographic impact of Alexandre Bleibtreu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Bleibtreu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Bleibtreu more than expected).

Fields of papers citing papers by Alexandre Bleibtreu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Bleibtreu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Bleibtreu. The network helps show where Alexandre Bleibtreu may publish in the future.

Co-authorship network of co-authors of Alexandre Bleibtreu

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Bleibtreu. A scholar is included among the top collaborators of Alexandre Bleibtreu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Bleibtreu. Alexandre Bleibtreu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jaquet, Pierre, Daniel Silva, Elena Papa, et al.. (2025). Two Cases of Autochthonous West Nile Virus Encephalitis, Paris, France, 2025. Emerging infectious diseases. 31(11). 2172–2174.
2.
Piroth, Lionel, Virginie Vitrat, Vincent Le Moing, et al.. (2025). Real-world use, effectiveness, and safety of ceftazidime-avibactam: Results of the French cohort OZAVIE. Infectious Diseases Now. 55(2). 105036–105036.
3.
Bleibtreu, Alexandre, et al.. (2025). Phage Therapy as a Rescue Treatment for Recurrent Pseudomonas aeruginosa Bentall Infection. Viruses. 17(1). 123–123. 3 indexed citations
6.
Eldin, Carole, et al.. (2024). Treatment of persistent focalized Q fever: time has come for an international randomized controlled trial. Journal of Antimicrobial Chemotherapy. 79(8). 1725–1747. 2 indexed citations
7.
Foy, Jean‐Philippe, et al.. (2024). Postoperative infections after sinus lifts and onlay grafts in penicillin allergic patients. Journal of Stomatology Oral and Maxillofacial Surgery. 125(5). 101764–101764. 1 indexed citations
9.
Dechartres, Agnès, et al.. (2023). Fungal versus non-fungal supra-inguinal prosthetic vascular graft infections: A cohort study. Infectious Diseases Now. 54(1). 104792–104792. 1 indexed citations
10.
Aubry, Alexandra, et al.. (2023). Impact of clinical pharmacist interventions in a bone and joint infection orthoseptic surgery unit. Annales Pharmaceutiques Françaises. 81(5). 826–832. 1 indexed citations
11.
Hansmann, Yves, Massimo Lodi, Cameron Mura, et al.. (2022). 3D-printed simulator for nasopharyngeal swab collection for COVID-19. Infectious Diseases Now. 52(3). 138–144. 1 indexed citations
12.
Yordanov, Youri, Aurélien Dinh, Alexandre Bleibtreu, et al.. (2021). Clinical characteristics and factors associated with hospital admission or death in 43 103 adult outpatients with coronavirus disease 2019 managed with the Covidom telesurveillance solution: a prospective cohort study. Clinical Microbiology and Infection. 27(8). 1158–1166. 30 indexed citations
13.
Bleibtreu, Alexandre, et al.. (2020). Autism and COVID-19: A Case Series in a Neurodevelopmental Unit. Journal of Clinical Medicine. 9(9). 2937–2937. 17 indexed citations
14.
Launay‐Vacher, Vincent, Alexandre Bleibtreu, Perrine Bortolotti, et al.. (2019). Antibiotics and chronic kidney disease: Dose adjustment update for infectious disease clinical practice. Médecine et Maladies Infectieuses. 50(4). 323–331. 20 indexed citations
15.
Bru, J.P., S. Alfandari, Alexandre Bleibtreu, et al.. (2019). Carbapenems versus beta-lactam/beta-lactamase inhibitors to treat ESBL-producing Enterobacteriaceae infections. Médecine et Maladies Infectieuses. 50(4). 313–315. 2 indexed citations
16.
Bleibtreu, Alexandre, et al.. (2019). Focus on Middle East respiratory syndrome coronavirus (MERS-CoV). Médecine et Maladies Infectieuses. 50(3). 243–251. 70 indexed citations
17.
Bleibtreu, Alexandre, Stéphane Jauréguiberry, Nadira Houhou, et al.. (2018). Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016. BMC Infectious Diseases. 18(1). 331–331. 29 indexed citations
18.
Zieliński, M., Johan Pluvy, V. Grégoire, et al.. (2017). Case of disseminated histoplasmosis in a HIV-infected patient revealed by nasal involvement with maxillary osteolysis. BMC Infectious Diseases. 17(1). 328–328. 8 indexed citations
19.
Surgers, Laure, Alexandre Bleibtreu, Charles Burdet, et al.. (2014). Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses. Clinical Microbiology and Infection. 20(12). O1035–O1041. 29 indexed citations
20.
Monnet, Xavier, Martin Dres, Alexis Ferré, et al.. (2012). Prediction of fluid responsiveness by a continuous non-invasive assessment of arterial pressure in critically ill patients: comparison with four other dynamic indices. British Journal of Anaesthesia. 109(3). 330–338. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026